|
HS Code |
657739 |
| Cas Number | 25952-53-8 |
| Molecular Formula | C8H17N3 |
| Molecular Weight | 155.24 |
| Synonyms | EDC, EDCI, EDAC, Water-Soluble Carbodiimide |
| Appearance | White to off-white crystalline powder |
| Solubility | Soluble in water and organic solvents |
| Melting Point | 110-115°C |
| Boiling Point | Decomposes before boiling |
| Density | 1.02 g/cm³ |
| Storage Temperature | 2-8°C |
| Purity | Typically ≥ 98% |
| Odor | Slight amine-like |
| Stability | Stable under recommended conditions |
As an accredited 1-(3-Dimethylaminopropyl)-3-Ethylcarbodiimide factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | White, tightly sealed plastic bottle with a blue screw cap containing 25 grams of 1-(3-Dimethylaminopropyl)-3-Ethylcarbodiimide, labeled with hazard warnings. |
| Shipping | 1-(3-Dimethylaminopropyl)-3-Ethylcarbodiimide is typically shipped in tightly sealed containers under cool, dry conditions to prevent moisture exposure and degradation. Transport follows standard chemical safety regulations, including labeling and documentation for hazardous materials if applicable. Ensure the package is secure and protected from physical damage during transit. Handle with appropriate personal protective equipment. |
| Storage | **1-(3-Dimethylaminopropyl)-3-Ethylcarbodiimide** should be stored in a tightly closed container, in a cool, dry, and well-ventilated area away from moisture and incompatible substances such as strong acids and bases. Protect from light and heat. Handle under inert atmosphere if possible, as this chemical can be sensitive to moisture and may degrade upon exposure to air or water. |
Applications of 1-(3-Dimethylaminopropyl)-3-Ethylcarbodiimide in Industrial ManufacturingAs a direct producer of 1-(3-Dimethylaminopropyl)-3-ethylcarbodiimide (EDC·HCl), we support leading manufacturers across multiple sectors that depend on water-soluble carbodiimide coupling for advanced synthesis and formulation. Our EDC·HCl delivers high reactivity and low residuals for demanding production needs in biomolecule, polymer, and specialty material industries. Explore key, evidence-based application areas below for practical guidance on compliance, usage, and formulation in downstream operations. 1. Peptide Synthesis for Pharmaceutical IntermediatesPeptide manufacturing relies on EDC·HCl for carbodiimide-mediated condensation reactions, driving the formation of peptide bonds with high yield, especially in solid- and solution-phase synthesis. Typical users are contract development and manufacturing organizations (CDMOs), API plants, and research institutions preparing therapeutic peptides, diagnostic reagents, and oligonucleotide conjugates. The material is chosen for its water solubility, reduced side reactions, and minimal urea byproduct interference, essential for meeting pharmaceutical-grade purity standards. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Protein Crosslinking in Antibody and Enzyme ConjugatesEDC·HCl is routinely adopted in immunoassay kit manufacture for covalent coupling of carboxyl and amine groups on proteins, facilitating antibody–enzyme, peptide–dye, and carrier–hapten crosslinking. QC laboratories and diagnostics companies favor this approach to achieve stable protein conjugates without introducing organic solvents. The coupling chemistry supports repeatable lot-to-lot performance critical for regulatory submissions and in vitro diagnostic test reproducibility. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Carboxyl-Activation for Biopolymer Surface ModificationManufacturers of hydrogels, nanoparticles, and medical polymers employ EDC·HCl as a zero-length crosslinker for functionalizing surfaces containing carboxyl groups, optimizing for covalent immobilization of proteins, peptides, or bioactive ligands. Its use allows precise control of activation without introducing hydrophobic residues, maintaining aqueous compatibility—a preference for biocompatible implantables and advanced wound care materials. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Synthesis of Functional Polymers and Graft CopolymersSpecialty chemical plants and R&D centers leverage EDC·HCl as a carbodiimide coupling agent to activate carboxylic acids for amide or ester bond formation in the preparation of functional polymers. It is specifically chosen for water-soluble or hydrogel-forming polymers where organic-soluble carbodiimides are unsuitable, ensuring efficient grafting while minimizing hydrolysis and side-products in poly(acrylic acid), poly(L-glutamic acid), and related architectures. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
5. Preparation of Drug–Polymer Conjugates for Drug DeliveryPharmaceutical technology teams utilize EDC·HCl-mediated conjugation to couple therapeutic payloads—such as doxorubicin or paclitaxel—to carboxyl- or amine-functionalized polymers, producing drug–polymer conjugates with controlled release characteristics. This chemistry supports site-specific attachment while maintaining API integrity, essential for injectable and implantable drug systems requiring tight process controls and regulatory compliance. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive 1-(3-Dimethylaminopropyl)-3-Ethylcarbodiimide prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Years of sweating over reactors, troubleshooting purification bottlenecks, and fielding dozens of requests for new coupling reagents have shown our team what chemists actually need from agents like 1-(3-Dimethylaminopropyl)-3-ethylcarbodiimide. We have manufactured EDC—its standard shorthand—across thousands of kilograms and watched its role grow from a specialty lab tool into a core pillar of peptide synthesis, bioconjugate techniques, and surface chemistry. Building up our own high-purity specifications took more than a few failures, and the real-world ups and downs give this compound a story that’s much richer than what gets recited on a typical data sheet.
1-(3-Dimethylaminopropyl)-3-ethylcarbodiimide stands apart thanks to its well-balanced reactivity and manageable byproducts. Unlike DCC or DIC, two historic carbodiimides that still have their fans in older protocols, EDC brings water solubility into the mix and avoids introducing insoluble urea waste into the product stream.
We’ve run the precipitation-heavy DCC route for carboxyl activation in the past and know just how sticky, and sometimes persistent, that DCU byproduct can get in a filtration funnel. Our switch to EDC stopped those headaches almost overnight—the water-soluble urea formed by EDC doesn’t force a complicated recovery or leave you cursing as you scrape glassware.
Every manufacturing lot matters. In our shop, we don’t treat specs as numbers scribbled once and forgotten, but as goals that make or break a week’s worth of work. Reliable EDC builds upon assay, moisture, and a close eye on byproducts like N-ethyl-N'-(3-dimethylaminopropyl)urea. Chemists who run coupling reactions in water—especially in bioconjugation work—often ask about amine-to-amine reactivity and the impact of residual salts from the synthesis. After years of tweaking, controlling water content below 0.5% and holding assay above 98% have become standard. Keeping the diethylurea impurity low smoothens downstream purification—our own test batches revealed even a few tenths of a percent can force an extra chromatography step on delicate peptides.
We manufacture EDC as its hydrochloride salt. This format is deliberate: the free base carries risks of rapid hydrolysis and unreliable shelf life, especially if it sits in open air during humid seasons. Strong handling protocols, dry-room packaging, and careful HCl neutralization keep the salt’s integrity as high as possible. In our own stockrooms, the stability and long shelf life of the hydrochloride form cut down on waste and ensure project teams rarely have to scramble due to premature degradation.
The choice among coupling agents often turns on waste issues, reaction conditions, and safety. EDC delivers a unique balance across these areas. Unlike DCC, which requires harsh organic solvents and creates stubborn urea cakes, EDC dissolves cleanly in both water and common buffers, making it the backbone for many bioconjugate and peptide production flows. We have seen this play out repeatedly in lab and pilot runs. Analytical techs comment on how much less time goes into cleaning filtration systems after EDC batches versus DCC ones.
Whenever someone asks about cost, we share the blunt truth: prices depend on scale, but the savings show up in fast, clean purification and minimized solvent waste. Each lost day spent unclogging filters or running second cleanups eats into any reagent cost advantage. Over hundreds of production lots, EDC’s practical advantages outweigh nickel-and-dime accounting tricks.
Some labs use DIC, seeking a compromise between EDC and DCC. Our direct experience tells us DIC lacks EDC’s water compatibility and creates health and toxicity issues through its diisopropylurea byproduct. For any process needing direct workup in aqueous or mixed-phase systems—an increasing share of life sciences workflows—EDC shines.
The journey from gram-scale benchwork to multi-ton manufacturing taught us the devil truly lives in the details. EDC’s chemistry doesn’t tolerate moisture or thermal fluctuations. Our crews use closed systems and aggressive inert atmospheres from charging to final packaging. A single leaky valve, a poorly calibrated dryer, or a moment of inattention at the HCl addition step has, in the past, cost days of investigation and rework.
Over time, these lessons have built a stubborn discipline in our team. Infrared moisture probes, in-process NMR sampling, and careful pH adjustment now sit as second nature in the standard batch books. This diligence pays off downstream; researchers and production chemists get a reagent that performs as claimed, time after time. When you have real people at the other end counting on consistency, shortcuts quickly lose their appeal.
Nearly every commercial peptide project coming through our customer network ends up with EDC somewhere along the chain. The ability to couple carboxylic acids to primary amines under mild, aqueous-compatible conditions transformed the cost structure of solid-phase peptide synthesis and permitted more sensitive modifications, such as fluorescent tagging or PEGylation.
Our own manufacturing arm has fielded requests for gram and kilogram-scale bioconjugates, often with complex solubility challenges. Being able to blend EDC straight into water or buffered saline means less prep time and fewer organic solvent touchpoints, satisfying both process safety staff and downstream regulatory reviewers looking for cleaner supply chains.
During our collaborations with biotech startups, EDC has played a critical role in activating carboxylate groups on polysaccharides and synthetic polymers for conjugation to proteins or small molecules. The rapid kinetics in aqueous systems support processes where temperature and pH need tight control to prevent denaturation or side reactions. Chemical engineers in our own facility appreciate not needing to purge stacks of volatile organic solvents after each batch.
Analytical work, including surface immobilizations and microarray labelings, also relies on EDC’s fast activation—even at low temperatures—where other reagents might stall out or cause unwanted cross-linking.
Every chemical throws curveballs; EDC is no exception. Though less hazardous than many crosslinking agents, it still carries the typical risks of strong amines and carbodiimides. Eyes and skin need protection, and material safety data protocols are no empty exercise. Even after five years of improved dust control and glove materials, we still see the occasional workflow interruption due to accidental exposure. Emphasizing closed-loop charging and sealed blending systems pays long-term dividends, both in safety and lot consistency.
Some buyers ask whether EDC has hidden downstream risk, especially regarding environmental load. Our response: compare the water-friendly, minimally toxicurea byproduct to the waste produced by DCC, and the improvement becomes clear. Even persistent hydrophobic residues from failed DCC couplings remain a regulatory headache for years, while EDC reactions run to completion leave far more manageable traces.
Crude EDC often looks identical to high-purity lots, but the chemistry tells a different story. Early batches—before we tightened dehydration and packing steps—sometimes produced sluggish couplings and unexplained side products. The lesson was clear: real-world performance matters more than an optimistic COA.
Routine HPLC, Karl Fischer titrations, and urea impurity checks now back every lot release. Long experience has also led us to avoid lots with traces of dimethylaminopropylamine or unreacted carbodiimide. These can trigger false starts or even safety issues in scale-up settings. Every specification we enforce comes directly from mistakes endured and corrected, rather than marketing language alone.
Some large production partners also run duplicate quality control on incoming EDC. Their feedback loop has helped us synchronize in-house priorities with external expectations, closing gaps where analytical drift previously crept in.
Chemists and corporate buyers now ask more questions about life cycle impacts, regulatory harmonization, and waste management than ever before. Our own sustainability group keeps tabs on solvent volumes, packaging recyclability, and efforts to minimize hazardous effluents. EDC’s ability to function in water and at ambient temperatures aligns with modern green chemistry targets.
We trade hard-won process expertise with colleagues in environmental compliance, using the water solubility of the major byproduct to streamline filtration and minimize energy use in post-reaction workup. Plant managers say the shift to EDC from older carbodiimides shrank solvent storage needs by up to 20% across several lines—translating directly to fewer shipping runs and reduced fire risk.
Peptide manufacturers juggling REACH, TSCA, and NIH reporting also recognize that the less persistent waste from EDC removes much of the paperwork headache tied to hazardous material tracking and landfill restrictions. Years ago, our DCC-heavy workflows constantly triggered waste manifests, extra inspections, and special instructions for drum disposal. With EDC, reports drop in length and complexity, keeping more attention focused on core process improvements.
As life sciences open new chapters in drug discovery and diagnostics, our own production team keeps hearing about fresh demands for coupling chemistries that do not compromise on selectivity or stability. Nanoscale diagnostics, targeted drug conjugates, and novel biomaterials all call for reagents that bring both productivity and traceability. EDC answers this by giving synthetic flexibility without undermining product purity.
Some labs combining synthetic peptides with nanocarriers report that EDC’s ‘clean kill’ of water-soluble byproducts offers gains in downstream analytics—a finding we confirm with our own mass spec checks in contract projects. Fewer analyte peaks, less baseline noise, and easier interpretation win approval from regulatory partners and quality control both inside and outside our walls.
Long hours on the manufacturing floor show patterns the datasheets never mention. If the plant runs without sharp water control, EDC loses more than potency—it risks total spoilage. Any thermal excursion past tightly set boundaries reduces yield and purity. We turn down batch starts on days when humidity spikes outpace our drying gear, holding product quality as the non-negotiable target.
We’ve invested in advanced moisture removal and packaging lines with nitrogen purging, based on the hard evidence that trace water triggers hydrolysis even before a package leaves our site. Packaging specs chosen by our operators—double-sealed PE liners, desiccant pouches, tamperproof bins—are borne out of bitter lessons with earlier, simpler systems that allowed humidity creep or accidental contamination.
One challenge unique to EDC manufacturing concerns the final transfer and blending—keeping static charges managed and minimizing dust. Our workers receive routine refresher courses and safety gear updates. Even the trucks that transport bulk EDC undergo regular testing for leaks and humidity ingress.
EDC’s evolution from an obscure coupling aid to a global mainstay follows broader shifts in organic and bio-organic chemistry. We watched as mainstream peptide and oligonucleotide synthesis transitioned steadily away from sticky, ground-glass-staining reagents toward the streamlined, less troublesome EDC workflows. Major pharmaceutical and diagnostic producers tuned their procurement to favor reliability, clean processing, and regulatory acceptance.
The ongoing switch means chemical companies—us included—face steeper expectations around supply chain transparency, auditable batch records, and compliance with local and international standards. We keep triplicate batch records, digital and paper both, and conduct annual audits of internal protocols, updating training materials for new process technicians at least twice every year.
On a practical level, logistics teams have learned how important it is to time deliveries right for EDC, since the material’s active form needs protection from both moisture and excessive heat. Long supply routes, variable customs delays, and changes in global shipping compound the requirement to carefully plan lots in advance. A well-run supply line ensures no project sits waiting for activation chemistry.
Some products sell themselves with glossy brochures and oversold benefits. Our experience with 1-(3-Dimethylaminopropyl)-3-ethylcarbodiimide is different. Years of partnering with leading biotech, pharma, and industrial material customers have shown concrete advantages:
To a synthetic chemist, switching couplers goes beyond theory. Transitioning entire product lines to EDC, as our team helped several major peptide houses achieve, demystifies a once challenging stage in scale-up and commercial peptide manufacture. We maintain an open ear for process tweaks and suggestions, learning as much from customer purification outcomes as from our own round-the-clock analytics.
Looking ahead, more research teams will pursue complex syntheses, biomolecule assemblies, and new classes of polymer conjugates that need reliability and niche flexibility from carbodiimide chemistry. We position ourselves at the practical edge of EDC production, never content to simply repeat what worked last year.
We continue refining moisture control, particle management, and batch documentation, shaped by years of feedback from reactors, QC labs, and shipping docks alike. For chemists who value direct answers, reliable reactivity, and traceable origins, our EDC story provides both reassurance and a record of how close attention to detail transforms ordinary chemical manufacture into a dependable, enabling pillar of modern science.